Researchers find RNA-guided enzymes are more diverse and widespread than previously believed.
Made of components found in the human body, the programmable system is a step toward safer, targeted delivery of gene editing and other molecular therapeutics.
Four times faster than conventional PCR methods, new RADICA approach is highly specific, sensitive, and resistant to inhibitors.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
Expanding tissue samples before sequencing allows researchers to pinpoint locations of RNA molecules.
Two MIT faculty members earn funding from the G. Harold and Leila Y. Mathers Foundation.
Curiosity-driven basic science in the 1970s laid the groundwork for today’s leading vaccines against the novel coronavirus.
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.
Using these new particles, researchers could develop treatments for heart disease and other conditions.
Findings related to bacterial gene expression overturn fundamental assumptions about basic biological pathways.